Home › NCT07279350
Health Advocate for Children After Liver Transplant
Health Advocate for Children After Liver Transplant: A Hybrid Implementation Effectiveness RCT
Who can join
Ages 0 to 18 · All sexes
Full eligibility criteria
Inclusion Criteria: * Patient \<18 years old at the time of liver transplant * Received a liver transplant within past 90 days * Family endorses material economic hardship on 10-questions Accountable Healthcare Communities screening tool. * Will receive follow-up care for at least 2 years * Family can read or write English or Spanish * A Legally Authorized Representative (LAR) can provide consent, and for children (12-17 years of age, the child is willing/able to provide assent.) * Family has a working phone and smartphone device capable of receiving calls or virtual visits via Zoom. Exclusion Criteria: * Patient has severe cognitive impairment. * 18 years of age or older at the time of consent * Patient unwilling or unable to consent/participate * Patient is a ward of the state (e.g. foster care) since present circumstances may not be reflective of child's past or future circumstances. * Non-English, non-Spanish speakers as ICFs, HIPAA authorization form, surveys, and interviews will only be available in these 2 languages. Languages besides English and Spanish are excluded from this study.
About the study
The HEAL-Tx is a 90-day intervention, in which a Health Advocate works with eligible families to identify and apply for community-based resources, alert healthcare providers to challenges the family is encountering, and guide health system navigation (e.g., coordinating appointments). Families in the control arm will receive a printed handout that provides contact information for local community-based resources. Families in the treatment arm will receive HEAL-Tx.
What is being tested
- Health advocate (behavioral)
- Enhanced Control (behavioral)
Sponsor: University of California, San Francisco · Participants: 108 · Started: May 5, 2026
Contact the study team
- Bethany Reyna, BA, CCRP · Phone: 415-476-7748
Official record on ClinicalTrials.gov — NCT07279350
Locations in the U.S.
| California | University of California, San Francisco, San Francisco |
| Pennsylvania | University of Pittsburgh Medical Center | Children Hospital of Pittsburgh, Pittsburgh |
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.